---
figid: PMC3107100__nor03901
figlink: /pmc/articles/PMC3107100/figure/NOR039F1/
number: Fig. 1
caption: Genetic alterations in glioblastoma signal transduction pathways (adapted
  from Parsons et al). (A) Proliferation and survival signaling is altered in 88%
  of glioblastomas. (B) p53 signaling is altered in 87% of glioblastomas. (C) RB signaling
  is altered in 78% of glioblastomas. CCND2 indicates cyclin-D2; CDK indicates cyclin-dependent
  kinase; CDKN indicates cyclin-dependent kinase inhibitor; EGFR indicates epidermal
  growth factor receptor; FOXO indicates forkhead box-O; HER2 indicates human epidermal
  growth factor receptor-2; NF1 indicates neurofibromin; PDGFR indicates platelet-derived
  growth factor receptor; PI3K indicates phosphatidylinositol 3-kinase; PTEN indicates
  phosphatase and tensin homolog; RB1 indicates retinoblastoma protein-1; and SRC*
  indicates activated (phosphorylated) SRC. Figure  is adapted from The Cancer Genome
  Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma
  genes and core pathways. Nature 2008;455(7216):1061–1068.
pmcid: PMC3107100
papertitle: 'Pathway inhibition: emerging molecular targets for treating glioblastoma.'
reftext: Wolfgang Wick, et al. Neuro Oncol. 2011 Jun;13(6):566-579.
pmc_ranked_result_index: '58137'
pathway_score: 0.9001802
filename: nor03901.jpg
figtitle: Genetic alterations in glioblastoma signal transduction pathways (adapted
  from Parsons et al)
year: '2011'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3107100__nor03901.html
  '@type': Dataset
  description: Genetic alterations in glioblastoma signal transduction pathways (adapted
    from Parsons et al). (A) Proliferation and survival signaling is altered in 88%
    of glioblastomas. (B) p53 signaling is altered in 87% of glioblastomas. (C) RB
    signaling is altered in 78% of glioblastomas. CCND2 indicates cyclin-D2; CDK indicates
    cyclin-dependent kinase; CDKN indicates cyclin-dependent kinase inhibitor; EGFR indicates
    epidermal growth factor receptor; FOXO indicates forkhead box-O; HER2 indicates
    human epidermal growth factor receptor-2; NF1 indicates neurofibromin; PDGFR indicates
    platelet-derived growth factor receptor; PI3K indicates phosphatidylinositol 3-kinase;
    PTEN indicates phosphatase and tensin homolog; RB1 indicates retinoblastoma protein-1;
    and SRC* indicates activated (phosphorylated) SRC. Figure  is adapted from The
    Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines
    human glioblastoma genes and core pathways. Nature 2008;455(7216):1061–1068.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MDM2
  - CDKN2B
  - AKT3
  - SRC
  - NF1
  - AKT1
  - TP63
  - MET
  - PTEN
  - HRAS
  - KRAS
  - EGFR
  - AKT2
  - NRAS
  - EIF2AK3
  - MDMA
  - Cancer
  - Lung cancer
genes:
- word: MDM2.
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: CDKN2B.
  symbol: CDKN2B
  source: hgnc_symbol
  hgnc_symbol: CDKN2B
  entrez: '1030'
- word: AKT,
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: SRC
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: NF1,mutated
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: AKT,
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TP63,
  symbol: TP63
  source: hgnc_symbol
  hgnc_symbol: TP63
  entrez: '8626'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: /PTEN,mutated
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: RAS,
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS,
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: EGFR,mututed
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: AKT,
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RAS,
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PEK.
  symbol: PEK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
chemicals:
- word: MDMA
  source: MESH
  identifier: D018817
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
